Biofabrication of Silver Nanoparticles (AgNPs) Using Embelin for Effective Therapeutic Management of Lung Cancer
- PMID: 35990347
- PMCID: PMC9386231
- DOI: 10.3389/fnut.2022.960674
Biofabrication of Silver Nanoparticles (AgNPs) Using Embelin for Effective Therapeutic Management of Lung Cancer
Abstract
Nanobiotechnology is a burgeoning field of research with applications in cancer treatment, targeted chemotherapy, and molecular diagnosis. This study aims at the fabrication of silver nanoparticles using embelin derived from Embelia ribes to evaluate its anticancer property. Silver nanoparticles (AgNPs) have emerged as a novel nano-carrier for therapeutic agents with a wide range of medical capabilities due to their unique structural, physicochemical, and optical features. In our study, the particle size of fabricated AgNPs was measured as 25 nm, and the zeta potential was recorded as -5.42 mV, which indicates the good stability of embelin-derived AgNPs. The crystalline surface morphology was observed by SEM analysis. The FT-IR spectrum confirmed the reduction in silver ions (Ag+) by embelin, and the TEM analysis exhibited polydispersed Ag+ of 20-30 nm. The anticancer potential of embelin-fabricated AgNPs was investigated using in vitro studies on lung cancer cells by the MTT assay. The results revealed significant dose-dependent inhibition of cell proliferation against A549 cell lines. Embelin AgNP-induced apoptosis was measured by the annexin-V PI apoptosis assay, which exhibited significantly low necrotic cells as compared to apoptotic cells. Finally, the findings of our study suggest the anticancer potential of biofabricated embelin AgNPs, particularly against lung cancer cells.
Keywords: MTT assay; anticancer; apoptosis assay; biofabrication; embelin; lung cancer; silver nanoparticles.
Copyright © 2022 Jagtap, Garud, Puranik, Rudrapal, Ansari, Alomary, Alshamrani, Salawi, Almoshari, Khan and Warude.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Jain N, Priyanshu Jain P, Rajput D, Patil UK. Green synthesized plant-based silver nanoparticles: therapeutic prospective for anticancer and antiviral activity. Micro Nano Syst Lett. (2021) 9:5. 10.1186/s40486-021-00131-6 - DOI
-
- Balantrapu K, Goia DV. Silver nanoparticles for printable electronics and biological applications. J Mater Res. (2009) 24:2828–36. 10.1557/jmr.2009.0336 - DOI
-
- Vardhana J, Kathiravan G. Biosynthesis of silver nanoparticles by endophytic fungi Pestaloptiopsis pauciseta isolated from the leaves of Psidium guajava Linn. Int J Pharm Sci Rev Res. (2015) 31:29–31. 10.7897/2230-8407.0617 - DOI
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
